SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-122181
Filing Date
2024-04-29
Accepted
2024-04-29 16:00:27
Documents
3
Period of Report
2024-06-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d874273ddef14a.htm DEF 14A 587508
2 GRAPHIC g874273g03g03.jpg GRAPHIC 352557
3 GRAPHIC g874273g04g04.jpg GRAPHIC 222056
  Complete submission text file 0001193125-24-122181.txt   1380166
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39617 | Film No.: 24890431
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)